Essais liés2clinical trials
VilleTel Avivlocalisation
PaysIsraellocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06392386

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
AMG334 Migraine Phase 4 NCT03927144 Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients COMPLETED
Efgartigimod PH20 SC Myasthénie Phase 2/3 NCT06392386 ADAPT Jr SC — A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis RECRUITING